These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7867991)

  • 1. Clinical problems of infectious complications in patients with multiple myeloma.
    Goranov S
    Folia Med (Plovdiv); 1994; 36(1):41-6. PubMed ID: 7867991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
    Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S
    Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.
    Blimark C; Holmberg E; Mellqvist UH; Landgren O; Björkholm M; Hultcrantz M; Kjellander C; Turesson I; Kristinsson SY
    Haematologica; 2015 Jan; 100(1):107-13. PubMed ID: 25344526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of biclonal myelomas.
    Goranov S
    Folia Med (Plovdiv); 1994; 36(4):31-6. PubMed ID: 8698283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of intravenous immune globulin in multiple myeloma.
    Chapel HM; Lee M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):21-4. PubMed ID: 8033429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocomplementemia in multiple myeloma.
    Lugassy G; Platok I; Schlesinger M
    Leuk Lymphoma; 1999 Apr; 33(3-4):365-70. PubMed ID: 10221517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcaemia and azotaemia in multiple myeloma--clinical and biochemical parallels.
    Goranov S
    Folia Med (Plovdiv); 1994; 36(1):47-53. PubMed ID: 7867992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma: infectious complications.
    Doughney KB; Williams DM; Penn RL
    South Med J; 1988 Jul; 81(7):855-8. PubMed ID: 3393943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal onset of multiple myeloma].
    Goranov S; Atanasov K; Dimitrakov D; Vakhrilov V; Diukmedzhiev I
    Vutr Boles; 1988; 27(2):74-9. PubMed ID: 3414104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988.
    Rayner HC; Haynes AP; Thompson JR; Russell N; Fletcher J
    Q J Med; 1991 Jun; 79(290):517-25. PubMed ID: 1946932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.
    Park S; Jung CW; Jang JH; Kim SJ; Kim WS; Kim K
    Transpl Infect Dis; 2015 Oct; 17(5):679-87. PubMed ID: 26201517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors.
    Valković T; Gačić V; Ivandić J; Petrov B; Dobrila-Dintinjana R; Dadić-Hero E; Načinović-Duletić A
    Turk J Haematol; 2015 Sep; 32(3):234-42. PubMed ID: 26376590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma presenting with an acute bacterial infection.
    Kalambokis GN; Christou L; Tsianos EV
    Int J Lab Hematol; 2009 Aug; 31(4):375-83. PubMed ID: 19486365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin therapy in patients with multiple myeloma.
    Chapel HM; Hargreaves R; Lee M; Pamphilon D
    Immunodeficiency; 1993; 4(1-4):77-8. PubMed ID: 8167740
    [No Abstract]   [Full Text] [Related]  

  • 16. Current patterns of bacterial infection in myelomatosis.
    Espersen F; Birgens HS; Hertz JB; Drivsholm A
    Scand J Infect Dis; 1984; 16(2):169-73. PubMed ID: 6740248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure in patients with multiple myeloma.
    Goranov S
    Folia Med (Plovdiv); 1996; 38(2):57-63. PubMed ID: 9002362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO; Laurain E; Cridlig J; Hulin C; Cao-Huu T; Frimat L
    Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications.
    Blombery P; Prince HM; Worth LJ; Main J; Yang M; Wood EM; Westerman DA
    Ann Hematol; 2011 Oct; 90(10):1167-72. PubMed ID: 21674144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.